SMC
SMC (Scientific Molding Corporation, Ltd.) is a privately held, FDA-registered medical contract manufacturer and pharmaceutical CDMO founded in 1988, operating 11 facilities across the US, Costa Rica, UK, and India to produce custom single-use medical devices, diagnostics consumables, and combination drug-device products for leading medtech, diagnostics, and pharma OEMs.
- Company typePrivate
- Founded1988
- HeadquartersSomerset, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What SMC does
SMC (Scientific Molding Corporation, Ltd.) is a privately held, Somerset, Wisconsin-headquartered contract manufacturer founded in 1988 that serves the medical device, diagnostics, and pharmaceutical industries on a strictly B2B basis. With 1,001–5,000 employees across 11 manufacturing and engineering facilities in the United States, Costa Rica, the United Kingdom, and India, SMC describes itself as a "best-in-class" contract manufacturer producing single-use and disposable medical products ranging from surgical devices and specialty syringes to diagnostic cartridges and combination drug-device products. The company holds FDA registration, ISO 13485, ISO 14001, MedAccred, and Bio Level 2 certifications across its global footprint, enabling it to support customers from concept through commercialization in regulated combination-product manufacturing.
The technology core of SMC combines in-house precision tooling, silicone liquid injection molding (LIM), thermoplastic injection molding, micro molding, automation, assembly, and cleanroom manufacturing, with stated capability to produce complex silicone parts in nearly half the lead time of traditional molding. SMC owns three registered, exclusive autoinjector drug-delivery platforms—ArQ (subcutaneous, low-to-medium viscosity, 0.5–1 mL), Bios (large-volume, ultra-high viscosity up to 1000+ cP, 1–5 mL), and Vita (long-acting IM/SC, 0.5–2 mL with resuspension technology)—that it offers to pharma customers as customizable combination-product foundations rather than off-the-shelf products. The Cambridge, UK site (acquired as Oval Medical Technologies in 2016) anchors the autoinjector engineering pipeline, while the Concord, NC sterile fill-finish facility, acquired in 2023, has extended SMC into upstream pharmaceutical services including formulation development, fill-finish, analytical testing, and serialized GMP packaging.
Commercially, SMC generates revenue via three streams: contract manufacturing fees for custom medical devices and diagnostics (professional services model with custom quote-based pricing), CDMO-style pharma services for combination products under FDA 21 CFR Part 4 (development services, clinical manufacturing, sterile fill-finish, commercial production), and licensing/customization of the proprietary autoinjector platforms. Distribution is entirely direct enterprise sales through dedicated program managers and subject-matter experts, with customer engagement described as starting at the early design phase and running through global fulfillment. Reported customers include unnamed leading medtech OEMs, diagnostics companies, and pharmaceutical firms, with the company stating partnerships with 15 of the top 30 medtech companies; key stated use cases include point-of-care sepsis diagnostic cartridges, peripheral stent delivery catheters, an atrial fibrillation mapping catheter detecting 64 signals simultaneously, and a 140-SKU lift-and-shift transition executed in Costa Rica.
SMC firmographics
Firmographics- Name
- SMC
- Legal name
- Scientific Molding Corporation, Ltd.
- Website
- https://smcltd.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SMC (Scientific Molding Corporation, Ltd.) is a privately held, FDA-registered medical contract manufacturer and pharmaceutical CDMO founded in 1988, operating 11 facilities across the US, Costa Rica, UK, and India to produce custom single-use medical devices, diagnostics consumables, and combination drug-device products for leading medtech, diagnostics, and pharma OEMs.
- Ownership category
- akta.pro rank
SMC industry classification
Industry- Product category
- Medical Device Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391), Medical Equipment and Supplies Manufacturing (33911), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
Keywords
Where SMC is headquartered
LocationHeadquarters
- HQ city
- Somerset
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
SMC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Contract Manufacturing: Fee-for-service contract manufacturing providing custom manufacturing of single-use and disposable medical devices. Revenue generated through direct manufacturing fees based on volume, complexity, and specific customer requirements. Services include design and development, injection molding, assembly, and packaging.
- Pharma Services: End-to-end pharmaceutical services including drug delivery device manufacturing, fill-finish capabilities, analytical services, and packaging. Revenue from development services, clinical manufacturing, and commercial production under FDA CFR 21 Part 4 compliance for combination products.
- Proprietary Autoinjector Platform Licensing: SMC offers their proprietary autoinjector platforms (ArQ, Bios, Vita) exclusively to customers, providing customization for specific drug formulations. Revenue model involves platform licensing and customization services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
SMC product offering
Product offeringCore offering
SMC provides end-to-end contract manufacturing of single-use and disposable medical devices for medtech, diagnostics, and pharmaceutical OEMs, including design and development, injection molding, assembly, packaging, and global distribution. The company also operates as a pharmaceutical CDMO offering sterile fill-finish, analytical, and development services under FDA CFR 21 Part 4 compliance for combination products, complemented by three proprietary autoinjector platforms (ArQ, Bios, Vita) offered exclusively to customers for drug delivery.
Product overview
SMC (Scientific Molding Corporation) is a global medical device and pharmaceutical contract manufacturing organization (CDMO) offering end-to-end manufacturing solutions from concept through commercialization. The company's portfolio centers on three proprietary autoinjector platforms—ArQ, Bios, and Vita—which are offered exclusively to customers as customizable drug delivery solutions. Beyond these device platforms, SMC provides comprehensive contract manufacturing services including design and development engineering, injection molding (silicone, thermoplastics, micro/mini components), supply chain management, quality and regulatory compliance, sterile fill-finish, analytical services, and assembly/labeling/packaging solutions. The company operates exclusively in the healthcare sector, serving medtech, diagnostics, and pharmaceutical markets across 11 global manufacturing facilities.
Differentiator
Problem solved
Functional benefit
Brands
- ArQ: Subcutaneous autoinjector platform with simple two-step user interface, capable of delivering low to medium viscosities up to 1 mL with viscosity up to 100cP
- Bios
- Vita
Products and services
- Contract Manufacturing Services
Quantifiable outcome
- Complex silicone parts produced repeatedly in nearly half the lead-time as traditional silicone molding options
- +2 more outcomes
Companies that use SMC
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
SMC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
SMC partnerships and signals
Strategic signalScale indicators6 records
Recent moves10 records
Expansion highlights5 records
SMC competitors and assessment
Company assessmentDirect peers
- SHL Medical: Pure-play autoinjector and pen-injector device specialist serving top pharma companies — the most direct head-to-head competitor to SMC's autoinjector platform business.
- Integer Holdings: Medical device contract manufacturer serving medtech OEMs across interventional, surgical and drug-delivery categories — direct peer in custom medical device manufacturing.
- Stevanato Group: Provider of drug containment, drug-delivery devices and analytical/sterile fill-finish services — overlap with SMC's combination-product and pharma services business.
- Gerresheimer: Pharmaceutical packaging and drug-delivery device manufacturer (autoinjectors, inhalers, prefilled syringes) — directly comparable in combination-product device space.
- West Pharmaceutical Services: Global leader in primary packaging, drug-delivery devices (including autoinjector platforms) and injectable containment — direct competitor to SMC's ArQ/Bios/Vita autoinjector platforms.
- Ypsomed: Swiss developer and manufacturer of autoinjectors, pen injectors and wearable injection systems — competing head-on with SMC's drug-delivery device platforms.
- Owen Mumford: Drug-delivery device specialist (autoinjectors, pen injectors) with in-house design and manufacturing — overlaps with SMC's autoinjector platform business.
- Phillips Medisize (Molex): Medical device and drug-delivery CDMO offering design, molding, assembly and combination-product services to medtech and pharma OEMs — directly comparable to SMC's contract manufacturing value proposition.
Emerging players
- Recipharm: Pharmaceutical CDMO with sterile fill-finish and injectable manufacturing capabilities — comparable to SMC's pharma services / sterile fill-finish franchise.
Broad incumbents
- Catalent (Novo Holdings): Large global CDMO offering biologics development, sterile fill-finish, and drug-delivery device services — broader portfolio but competes for the same pharma combination-product programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SMC social profiles
Digital presenceSMC compliance and trust
Trust signalCompliance6 records
SMC financial estimates
Financial estimateRevenue estimate
Valuation estimate
SMC leadership team
Management profileNumber of profiles
Profiles4 records
SMC subsidiaries and ownership
Company hierarchySubsidiaries2 records
SMC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SMC M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SMC
What does SMC do?
SMC provides end-to-end contract manufacturing of single-use and disposable medical devices for medtech, diagnostics, and pharmaceutical OEMs, including design and development, injection molding, assembly, packaging, and global distribution. The company also operates as a pharmaceutical CDMO offering sterile fill-finish, analytical, and development services under FDA CFR 21 Part 4 compliance for combination products, complemented by three proprietary autoinjector platforms (ArQ, Bios, Vita) offered exclusively to customers for drug delivery.
Is SMC a public or private company?
SMC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SMC founded?
SMC was founded in 1988. It employs 1,001 to 5,000 people.
Where is SMC based?
SMC is headquartered in Somerset, United States, in the North America region.
How does SMC make money?
Three revenue lines are on record. Medical Device Contract Manufacturing is the primary driver. The others are pharma Services and proprietary Autoinjector Platform Licensing.
Who are SMC's main competitors?
Direct peers on record are SHL Medical, Integer Holdings, Stevanato Group, Gerresheimer, West Pharmaceutical Services, Ypsomed, Owen Mumford and Phillips Medisize (Molex). Recipharm is listed as an emerging player. Catalent (Novo Holdings) is listed as a broad incumbent.
Does SMC have an API?
No public API is recorded for SMC.
What industry is SMC in?
SMC's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 325412 and its SIC code is 2834.